Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Molecular Cancer Therapeutics|June 10, 2010
Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in miceVanessa Fritz, Zohra Benfodda, Geneviève Rodier, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune SignaturesJacqueline Fontugne, Evanguelos Xylinas, Clémentine Krucker, et al.
International Journal of Cancer|October 15, 2013
PI3K/AKT pathway activation in bladder carcinogenesisJulien Calderaro, Sandra Rebouissou, Leanne de Koning, et al.
Non-Coding RNA|August 24, 2019
High Positive Correlations between <i>ANRIL</i> and <i>p16</i>-<i>CDKN2A</i>/<i>p15</i>-<i>CDKN2B</i>/<i>p14</i>-<i>ARF</i> Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an <i>ANRIL-ARF</i> Bidirectional PromoterKinan Drak Alsibai, Sophie Vacher, Didier Meseure, et al.
Journal of the National Cancer Institute|October 31, 2012
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological studyAndré F S Amaral, Marinela Méndez-Pertuz, Alberto Muñoz, et al.
BJU International|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinomaPierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
Cancers|October 14, 2020
Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder CancerSophie Vacher, Voreak Suybeng, Elodie Girard, et al.
European Urology|April 7, 2007
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patientsGuillaume Guichard, Stéphane Larré, Andrea Gallina, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Molecular Cancer Therapeutics|June 10, 2010
Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in miceVanessa Fritz, Zohra Benfodda, Geneviève Rodier, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune SignaturesJacqueline Fontugne, Evanguelos Xylinas, Clémentine Krucker, et al.
International Journal of Cancer|October 15, 2013
PI3K/AKT pathway activation in bladder carcinogenesisJulien Calderaro, Sandra Rebouissou, Leanne de Koning, et al.
Non-Coding RNA|August 24, 2019
High Positive Correlations between <i>ANRIL</i> and <i>p16</i>-<i>CDKN2A</i>/<i>p15</i>-<i>CDKN2B</i>/<i>p14</i>-<i>ARF</i> Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an <i>ANRIL-ARF</i> Bidirectional PromoterKinan Drak Alsibai, Sophie Vacher, Didier Meseure, et al.
Journal of the National Cancer Institute|October 31, 2012
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological studyAndré F S Amaral, Marinela Méndez-Pertuz, Alberto Muñoz, et al.
BJU International|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinomaPierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
Cancers|October 14, 2020
Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder CancerSophie Vacher, Voreak Suybeng, Elodie Girard, et al.
European Urology|April 7, 2007
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patientsGuillaume Guichard, Stéphane Larré, Andrea Gallina, et al.
Pageof 21